Udenafil CAS 268203-93-6

Udenafil is the fourth in a class of drugs targeting the inhibition of the enzyme phosphodiesterase 5 (PDE5) for the treatment of erectile dysfunction. Inhibition of PDE5 results in the increase in endogenous cyclic guanosine monophosphate (cGMP) concentrations in the penile corpus cavernosum. cGMP induces smooth muscle cell relaxation and subsequent increased blood flow leading to a sustainable erection. Udenafil is a potent antagonist of human PDE5 with an IC₅₀ of 8.25nM and a comparable selectivity profile as sildenafil for the other PDEs. Unlike tadalafil, it does not inhibit PDE11, which has been implicated in myalgia and testicular toxicity. Furthermore, udenafil produced up to a 91% vaginal penetration success rate and up to a 67% intercourse completion rate compared to a 29% completion rate by placebo. Overall patient satisfaction, measured by a standard global assessment question, was 86% compared to only 26% in the placebo group. The most frequently recorded adverse events were mild-to-moderate facial flushing and headache.

Udenafil is an inhibitor of phosphodiesterase 5 (PDE5). In vivo, udenafil (1 and 5 mg/kg) increases lung cGMP levels, attenuates the development of compensatory right ventricular hypertrophy, and reduces pulmonary arterial wall thickening in a rat model of monocrotaline-induced pulmonary hypertension. It increases creatine clearance and decreases blood urea nitrogen (BUN) and serum malondialdehyde (MDA) levels in a rat model of renal ischemia-reperfusion injury. Udenafil (0.3 and 10 mg/kg) induces penile erections in conscious rabbits and in rabbits with acute spinal cord injury.

Tha mòran fhactaraidhean àrd-inbhe againn le co-obrachadh domhainn, a bheir dhut toraidhean àrd-inbhe agus prìsean farpaiseach. Agus is urrainn dhuinn cuideachd lasachaidhean a thoirt seachad airson mòr-cheannach. Tha an ùine lìbhrigidh timcheall air 3-20 latha às deidh dearbhadh pàighidh.

Product Name:	Udenafil
Synonyms:	5-[2-propyloxy-5-(2-(1-Methylpyrrolidin-2-yl)ethylaMinosulphonyl)phenyl]-1-Methyl-3-propyl-6,7-dihydro-1H-pyrazolo(4,3-d)pyriMidin-7-one;5-[2-propyloxy-5-[2-(1-Methyl-2-pyrrolidinyl)ethylaMinosulfonyl]phenyl]-1-Methyl-3-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyriMidine-7-one;Zydena;Udenafil(DA 8159,Zydena);BenzenesulfonaMide,3-(6,7-dihydro-1-Methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-d]pyriMidin-5-yl)-N-[2-(1-Methyl-2-pyrrolidinyl)ethyl]-4-propoxy-;Udenafil, DA 8159;CS-1353;Udenafil, >=98%
CAS:	268203-93-6
MF:	C25H36N6O4S
MW:	516.66
EINECS:	251-228-4
Product Categories:	Intermediates & Fine Chemicals;Pharmaceuticals
Mol File:	268203-93-6.mol

1. An e factaraidh no companaidh malairt a th 'annad?
Tha sinn nar companaidh a tha ag amalachadh gnìomhachas agus malairt, a’ toirt seachad seirbheis aon-stad. Dh’ fhaodadh gabhail ri OEM.

2. A bheil thu a 'toirt seachad samples? A bheil e an-asgaidh no a bharrachd?
Saor an-asgaidh samples.The shampall cìs bathair feumar pàigheadh ​​le ur taobh.

3. A bheil teisteanasan sam bith agad co-cheangailte ri smachd càileachd?
Teisteanas ISO 9001: 2008 gus dèanamh cinnteach à càileachd.

4. Dè a bu chòir dhomh a thoirt seachad gus luachan fhaighinn?
Bidh Pls ag innse dhuinn mun t-seòrsa toraidh a dh’ fheumas tu, meud òrduigh, seòladh agus riatanasan sònraichte. Thèid an luachan a dhèanamh airson do iomradh ann an ùine.

5. Dè an seòrsa dòigh pàighidh as fheàrr leat? Dè an seòrsa teirmean ris an tèid gabhail?
Cumhachan Lìbhrigeadh ris an deach gabhail: FOB, CFR, CIF, EXW;
Airgead pàighidh ris an deach gabhail: USD;
Seòrsa Pàighidh ris an deach gabhail: T / T, Western Union; Paypal, Dearbhadh Malairt.
Cànan air a labhairt: Beurla.